Of interest, during longitudinal tumor ctDNA monitoring, we discovered that one patient with recurrent USC lost genetic mutations originally identified in her primary uterine tumor, which had been considered “driver gene mutations” (i.e., TP53), while other “driver” mutations (i.e., PIK3CA) remained detectable in plasma. The gene discussed is PIK3CA; the disease is tumor of uterus.